These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10392065)

  • 1. Low seroconversion for hepatitis C virus (HCV) antibody achieved by universal precautions alone.
    Flett A; Teo M; Mah YI; Mortlock F; Choo BB; Challinor SP; Woods HF
    EDTNA ERCA J; 1998; 24(2):40-2. PubMed ID: 10392065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal precautions and dedicated machines as cheap and effective measures to control HCV spread.
    Cerrai T; Michelassi S; Ierpi C; Toti G; Zignego AL; Lombardi M
    EDTNA ERCA J; 1998; 24(2):43-5, 48. PubMed ID: 10392066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis and transfusions.
    Donnelly K
    Nephrol Nurs J; 2000 Oct; 27(5):538-9. PubMed ID: 16649331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods used to reduce the prevalence of hepatitis C in a dialysis unit.
    Hussein MM; Mooij JM
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):909-13. PubMed ID: 20814130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viral hepatitis in hemodialysis patients].
    Yanai M
    Rinsho Byori; 2001 Mar; 49(3):249-53. PubMed ID: 11307324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection.
    Iwasaki Y; Esumi M; Hosokawa N; Yanai M; Kawano K
    J Hosp Infect; 2000 May; 45(1):54-61. PubMed ID: 10833344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of hepatitis C virus transmission in hemodialysis].
    Jadoul M; Poignet JL
    Nephrologie; 1997; 18(7):307-8. PubMed ID: 9496573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group.
    Jadoul M; Cornu C; van Ypersele de Strihou C
    Kidney Int; 1998 Apr; 53(4):1022-5. PubMed ID: 9551413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a national epidemiological investigation of HCV infection in dialysis patients.
    Lombardi M; Cerrai T; Geatti S; Negroni S; Pertusini L; Pegoraro M; Di Lullo G
    EDTNA ERCA J; 1999; 25(3):38-42. PubMed ID: 10786494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood borne virus-innovative approach to evaluate, prevent cross-transmission in dialysis units.
    Chow J; Miguel SS
    J Ren Care; 2008 Dec; 34(4):203-6. PubMed ID: 19090899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of viral transmission in HD units: the value of isolation.
    Karkar A; Abdelrahman M; Ghacha R; Malik TQ
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):183-8. PubMed ID: 16903625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neglect of special precautions is a real clinical risk in dialysis].
    Lombardi M; Cherubini C
    G Ital Nefrol; 2009; 26(5):625-31. PubMed ID: 19802809
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
    Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.
    Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S;
    Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran.
    Amiri ZM; Shakib AJ; Toorchi M
    East Mediterr Health J; 2005 May; 11(3):372-6. PubMed ID: 16602456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection control of hepatitis C in Dutch dialysis centres.
    Schneeberger PM; Toonen N; Keur I; van Hamersvelt HW
    Nephrol Dial Transplant; 1998 Dec; 13(12):3037-40. PubMed ID: 9870462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of selective screening in the emergency department on meticillin-resistant Staphylococcus aureus control programmes.
    Eveillard M; Leroy C; Teissiere F; Lancien E; Branger C; de Lassence A; Joly-Guillou ML; Brun P
    J Hosp Infect; 2006 Aug; 63(4):380-4. PubMed ID: 16759741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients.
    Ross RS; Viazov S; Clauberg R; Wolters B; Fengler I; Eveld K; Scheidhauer R; Hüsing J; Philipp T; Kribben A; Roggendorf M
    J Viral Hepat; 2009 Apr; 16(4):230-8. PubMed ID: 19175869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.